Sign in with Google. Opens in new tab
ENTITY
SMARTSCORE: 3.4/5

Shenzhen Weiguang Biologic-A (002880 CH)

3
Analysis
Health CareChina
Shenzhen Weiguang Biological Products Co., Ltd manufactures special pharmaceuticals. The Company mainly researches, develops, produces, and sells blood products. Shenzhen Weiguang Biological Products serves customers in China.
more
22 Jun 2025 01:58

China Healthcare Weekly (Jun.22) - CNPGC to Acquire Shuanglin, Thoughts on Zhou Liu Fu's IPO Pricing

CNPGC plan to acquire Pacific Shuanglin, bringing new M&A/privatization due to horizontal competition. Zhou Liu Fu's IPO is fairly priced, but...

Logo
327 Views
Share
08 Apr 2025 01:31

The Impact of Trump's Tariffs on China Healthcare - The Victims, And the Safe Haven Assets

As tariff war is heating up, some sectors in China healthcare will be victims, but there will also safe haven assets.The logic behind tariffs is to...

Logo
308 Views
Share
24 Apr 2024 00:55

Tiantan (600161CH) To Acquire Weiguang (002880CH)- New King Rises in China's Blood Products Industry

The change of Weiguang's actual controller will bring about a series of restructuring.As SOE reform enters new stage, investors will have good...

Logo
347 Views
Share
No more insights
x